LeMaitre Vascular Inc. (LMAT) shares slipped to a 52‑week low of $78.22, placing the price roughly 33% beneath the 52‑week high of $118.01. Over the last year the stock has declined 14.55%, according to the data provided. InvestingPro assigns the company a financial health score of 3.26, described as "GREAT," and notes a PEG ratio of 0.7.
The firm has increased its dividend for 15 consecutive years and holds more cash than debt on its balance sheet. In the second quarter LeMaitre Vascular reported adjusted earnings of $0.74 per share, below the analyst consensus of $0.81, and revenue of $70.4 million versus the expected $71.47 million. Despite posting strong year‑over‑year growth, the company revised its full‑year growth outlook downward.
